Skip to content

Acupuncture for Sequelae of Bell's Palsy

Acupuncture for Sequelae of Bell's Palsy: a randomised wait-list controlled pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN43104115
Enrollment
20
Registered
2010-07-06
Start date
2010-08-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sequelae of Bell's palsy Nervous System Diseases Facial nerve disorders

Interventions

The study includes the following periods in all groups: a treatment period of 8 weeks (3 sessions/week), and a follow-up period of 4 weeks. Acupuncture group: In the acupuncture treatment group, 18

Sponsors

Kyung Hee University (South Korea)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18-65 2. Diagnosis of Bell's palsy (ICD-10 G51.0), at least 6 months prior to recruitment 3. FDI (Facial Disability Index) score of below 70 in Physical Function, and below 80 in Social/Well-being Function 4. Provided written informed consent

Exclusion criteria

Exclusion criteria: 1. Secondary facial palsy resulting from specific disease such as infection, multiple neuritis, tumour invading the temporal region, cerebral contusion or stroke 2. Patient manifesting Ramsay-Hunt syndrome 3. Bilateral facial palsy 4. Recurred facial palsy 5. Received orally administered corticosteroids or anti-viral agent(aciclovir, valaciclovir, famciclovir, ganciclovir) within 1 month before enrolment 6. Received alternative and complementary modality, i.e. acupuncture, moxibustion, vesicant therapy or massage for treating Bell's palsy within 3 months 7. Received operation, i.e. facial nerve decompression, facial nerve and muscle reconstruction for treating Bell's palsy 8. Suffering serious medical condition such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment 9. Other neurologic illness 10. Participating in another clinical trial 11. Suffering psychiatric illness insufficient for participation in clinical trial 12. Unable to obtain written consent 13. Pregnant or nursing status, or planning conception during treatment 14. Scar in administration area or systemic illness unsuitable for acupuncture treatment in the judgement of the investigator

Design outcomes

Primary

MeasureTime frame
Changes in FDI (Facial Disability Index) after 24 sessions/8 weeks of acupuncture treatment.

Secondary

MeasureTime frame
Changes in the following, after 24 sessions/8 weeks of acupuncture treatment and one-month follow-up: 1. Sunnybrook Facial Grading System 2. H-B Scale 3. Lip-length and snout indices 4. Facial stiffness

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026